← back to search

Makoto Takeda

Osaka Medical and Pharmaceutical University · JP
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Virology and Viral Diseases, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, and Virus-based gene therapy research.
h-index
63
citations
16,819
works
409
NIH funding
primary concept
Biology
email

Recent publications

Feline morbillivirus elicits robust neutralizing antibodies in domestic cats without cross-neutralizing activities against canonical morbilliviruses
Journal of General Virology 2026cited by 0position: contributordoi
The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
2025cited by 6position: contributordoi
Evolutionary and structural basis of SLAMF1 utilization in morbilliviruses-Implications for host range and cross-species transmission.
2025cited by 1position: contributordoi
Improved RSV Neutralization Assay Using Recombinant RSV Expressing Reporter Fluorescent Protein.
2025cited by 1position: contributordoi
Serological Evidence of Cetacean Morbillivirus Infection in Common Bottlenose Dolphins in Japan.
2025cited by 0position: contributordoi
Cord Blood RSV-Neutralizing Antibodies and Risk of Hospitalization for RSV-Associated Acute Respiratory Infection in Vietnamese Children: A Case-Cohort Study.
2025cited by 0position: contributordoi
Evolutionary and structural basis of SLAM utilization in morbilliviruses – Its implications for host range and cross-species transmission
2025cited by 0position: contributordoi
Structural and molecular properties of mumps virus inclusion bodies.
2024cited by 7position: contributordoi
Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling
International Journal of Infectious Diseases 2024cited by 3position: middledoi
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2024cited by 0position: contributordoi
Author response: Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2024cited by 0position: contributordoi
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2024cited by 0position: contributordoi
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2024cited by 0position: contributordoi
Molecular Diversity of Human Respiratory Syncytial Virus before and during the COVID-19 Pandemic in Two Neighboring Japanese Cities.
2023cited by 8position: contributordoi
Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program
International Journal of Infectious Diseases 2023cited by 3position: middledoi
Generation of a photocontrollable recombinant bovine parainfluenza virus type 3.
2023cited by 1position: contributordoi
Demonstration of bacterium-free very rapid reverse genetics system using mumps virus.
2023cited by 1position: contributordoi
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2023cited by 0position: contributordoi
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2023cited by 0position: contributordoi
Glycan-shielded homodimer structure and dynamical features of the canine distemper virus hemagglutinin relevant for viral entry and efficient vaccination
2023cited by 0position: contributordoi
Proteolytic activation of SARS-CoV-2 spike protein.
2022cited by 144position: contributordoi
Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways.
2022cited by 84position: contributordoi
Novel and classical morbilliviruses: Current knowledge of three divergent morbillivirus groups.
2022cited by 10position: contributordoi
Variation in Thermal Stability among Respiratory Syncytial Virus Clinical Isolates under Non-Freezing Conditions.
2022cited by 10position: contributordoi
Practical Validation of United States Centers for Disease Control and Prevention Assays for the Detection of Human Respiratory Syncytial Virus in Pediatric Inpatients in Japan.
2022cited by 10position: contributordoi
Membrane Sphingomyelin in Host Cells Is Essential for Nucleocapsid Penetration into the Cytoplasm after Hemifusion during Rubella Virus Entry.
2022cited by 9position: contributordoi
Thirteen Nearly Complete Genome Sequences of Human Bocavirus 1 Isolated from Pediatric Inpatients in Fukushima, Japan.
2022cited by 8position: contributordoi
Nucleolar Protein Treacle Is Important for the Efficient Growth of Mumps Virus.
2022cited by 6position: contributordoi
Detection of the ORF1 Gene Is an Indicator of the Possible Isolation of Severe Acute Respiratory Syndrome Coronavirus 2.
2022cited by 6position: contributordoi
Ten Nearly Complete Genome Sequences of Human Orthorubulavirus 4 Isolated from Pediatric Inpatients in Fukushima, Japan.
2022cited by 5position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 55 papers (2019–2026)Katsumi Maenaka · Hokkaido University10 papers (2019–2025)Kazuya Shirato · Hokkaido University9 papers (2022–2025)Mwila Hilton Mwaba · Copperbelt University School of Medicine7 papers (2023–2024)Nobuo Maita · SpringerNature5 papers (2023–2024)Tadaki Suzuki · The University of Tokyo4 papers (2020–2024)Hiroshi Katoh · Yamagata Prefectural University of Health Sciences4 papers (2019–2024) · 4 papers (2018–2024) · 4 papers (2012–2019)Emilia Vynnycky · London School of Hygiene & Tropical Medicine4 papers (2018–2024) · 4 papers (2018–2024) · 4 papers (2018–2024) · 3 papers (2012–2016) · 3 papers (2022–2023)Noriyo Nagata · National Institute of Infectious Diseases3 papers (2022–2025)Tsuyoshi Sekizuka · National Institute of Infectious Diseases3 papers (2019–2024)Ko Sato · Mycologie et Sécurité des Aliments3 papers (2020–2022)Benhur Lee · University of California, San Diego3 papers (2021–2025) · 3 papers (2022–2023)Koichi Hashimoto · Fukushima Medical University3 papers (2022–2023)